Effect of prolotherapy with trigger point dextrose/levobupivacaine mixture injection on myofascial pain syndrome: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014444

Enrollment

Unknown

Registered

2018-01-15

Start date

2018-02-01

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain

Interventions

intervention:Injection of mixture

Control:sham treatment

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged 18 years old or above 2. Patient with musculoskeletal pain in trapezius muscle which has met the Travell and Simons criteria 3. Informed consent will be obtained from the patient in compliance with ICH-GCP.

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Patient on anticoagulant therapy 3. Patient with local skin infection 4. Allergy to study medication (25% dextrose + 0.25% levobupivacaine) 5. Mentally incapable patient 6. More than 3 Trigger points within the trapezius 7. Any form of injection/ acupuncture / dry needle therapy to MTrPs within 3 months

Design outcomes

Primary

Measure	Time frame
Visual analogue scale;	—

Countries

China

Contacts

Public ContactNg Hiu Ying

lettuceng@gmail.com+852 97888596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026